Literature DB >> 28566437

Local DNA Repair Inhibition for Sustained Radiosensitization of High-Grade Gliomas.

Amanda R King1, Christopher D Corso2, Evan M Chen1, Eric Song1, Paul Bongiorni2, Zhe Chen2, Ranjini K Sundaram2, Ranjit S Bindra3,4, W Mark Saltzman5.   

Abstract

High-grade gliomas, such as glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG), are characterized by an aggressive phenotype with nearly universal local disease progression despite multimodal treatment, which typically includes chemotherapy, radiotherapy, and possibly surgery. Radiosensitizers that have improved the effects of radiotherapy for extracranial tumors have been ineffective for the treatment of GBM and DIPG, in part due to poor blood-brain barrier penetration and rapid intracranial clearance of small molecules. Here, we demonstrate that nanoparticles can provide sustained drug release and minimal toxicity. When administered locally, these nanoparticles conferred radiosensitization in vitro and improved survival in rats with intracranial gliomas when delivered concurrently with a 5-day course of fractionated radiotherapy. Compared with previous work using locally delivered radiosensitizers and cranial radiation, our approach, based on the rational selection of agents and a clinically relevant radiation dosing schedule, produces the strongest synergistic effects between chemo- and radiotherapy approaches to the treatment of high-grade gliomas. Mol Cancer Ther; 16(8); 1456-69. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28566437      PMCID: PMC5545124          DOI: 10.1158/1535-7163.MCT-16-0788

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  73 in total

Review 1.  Blood-brain barrier delivery.

Authors:  William M Pardridge
Journal:  Drug Discov Today       Date:  2006-11-13       Impact factor: 7.851

Review 2.  Chemical strategies for development of ATR inhibitors.

Authors:  Sabin Llona-Minguez; Andreas Höglund; Sylvain A Jacques; Tobias Koolmeister; Thomas Helleday
Journal:  Expert Rev Mol Med       Date:  2014-05-09       Impact factor: 5.600

3.  Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat model.

Authors:  Minghan Shi; David Fortin; Léon Sanche; Benoit Paquette
Journal:  Invest New Drugs       Date:  2015-03-18       Impact factor: 3.850

4.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux.

Authors:  Sagar Agarwal; Ramola Sane; Jose L Gallardo; John R Ohlfest; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2010-04-26       Impact factor: 4.030

6.  Comprehensive profiling of radiosensitive human cell lines with DNA damage response assays identifies the neutral comet assay as a potential surrogate for clonogenic survival.

Authors:  Shareef A Nahas; Robert Davies; Francesca Fike; Kotoka Nakamura; Liutao Du; Refik Kayali; Nathan T Martin; Patrick Concannon; Richard A Gatti
Journal:  Radiat Res       Date:  2011-09-30       Impact factor: 2.841

7.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

8.  Brain distribution of cediranib is limited by active efflux at the blood-brain barrier.

Authors:  Tianli Wang; Sagar Agarwal; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2012-02-08       Impact factor: 4.030

9.  A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas.

Authors:  D I Guisado; R Singh; S Minkowitz; Z Zhou; S Haque; K K Peck; R J Young; A J Tsiouris; M M Souweidane; S B Thakur
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-03       Impact factor: 3.825

10.  Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress.

Authors:  Yao Zhang; Jinzhi Lai; Zhanwen Du; Jinnan Gao; Shuming Yang; Shashank Gorityala; Xiahui Xiong; Ou Deng; Zhefu Ma; Chunhong Yan; Gonzalo Susana; Yan Xu; Junran Zhang
Journal:  Oncotarget       Date:  2016-06-07
View more
  13 in total

1.  Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.

Authors:  Young-Eun Seo; Hee-Won Suh; Raman Bahal; Alexander Josowitz; Junwei Zhang; Eric Song; Jiajia Cui; Seth Noorbakhsh; Christopher Jackson; Tom Bu; Alexandra Piotrowski-Daspit; Ranjit Bindra; W Mark Saltzman
Journal:  Biomaterials       Date:  2019-02-14       Impact factor: 12.479

2.  Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors.

Authors:  Cecilia Lopez Sambrooks; Marta Baro; Amanda Quijano; Azeet Narayan; Wei Cui; Patricia Greninger; Regina Egan; Abhijit Patel; Cyril H Benes; W Mark Saltzman; Joseph N Contessa
Journal:  Cancer Res       Date:  2018-07-19       Impact factor: 12.701

Review 3.  The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.

Authors:  Susan E Gueble; Juan C Vasquez; Ranjit S Bindra
Journal:  Curr Treat Options Oncol       Date:  2022-10-15

4.  Nanomaterials for convection-enhanced delivery of agents to treat brain tumors.

Authors:  Young-Eun Seo; Tom Bu; W Mark Saltzman
Journal:  Curr Opin Biomed Eng       Date:  2017-09-22

5.  Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors.

Authors:  Evan M Chen; Amanda R Quijano; Young-Eun Seo; Christopher Jackson; Alexander D Josowitz; Seth Noorbakhsh; Andrea Merlettini; Ranjini K Sundaram; Maria Letizia Focarete; Zhaozhong Jiang; Ranjit S Bindra; W Mark Saltzman
Journal:  Biomaterials       Date:  2018-06-18       Impact factor: 12.479

6.  Nanoparticles for delivery of agents to fetal lungs.

Authors:  Sarah J Ullrich; Mollie Freedman-Weiss; Samantha Ahle; Hanna K Mandl; Alexandra S Piotrowski-Daspit; Katherine Roberts; Nicholas Yung; Nathan Maassel; Tory Bauer-Pisani; Adele S Ricciardi; Marie E Egan; Peter M Glazer; W Mark Saltzman; David H Stitelman
Journal:  Acta Biomater       Date:  2021-01-21       Impact factor: 8.947

Review 7.  Mesenchymal Epithelial Transition Factor Signaling in Pediatric Nervous System Tumors: Implications for Malignancy and Cancer Stem Cell Enrichment.

Authors:  Amanda Rose Khater; Tamara Abou-Antoun
Journal:  Front Cell Dev Biol       Date:  2021-05-13

8.  Observation of the impact of the eight-step process combined with the four-track crossover quality control applied to patients with glioma surgery: a randomised trial.

Authors:  Zhen Zhang; Jing Ma; Ying Xu; Huihui Zhang
Journal:  Ann Transl Med       Date:  2021-04

9.  REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature.

Authors:  Shavali Shaik; Bridget Kennis; Shinji Maegawa; Keri Schadler; Yang Yanwen; Keri Callegari; Rishi R Lulla; Stewart Goldman; Javad Nazarian; Veena Rajaram; Jason Fangusaro; Vidya Gopalakrishnan
Journal:  Oncotarget       Date:  2017-12-28

10.  Inhibition of the Spectraplakin Protein Microtubule Actin Crosslinking Factor 1 Sensitizes Glioblastomas to Radiation.

Authors:  Kala Bonner; Danielle Borlay; Orica Kutten; Quincy A Quick
Journal:  Brain Tumor Res Treat       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.